Ivermectin to Prevent Hospitalizations in COVID-19

NCT04529525 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

501

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Ivermectin
DRUG: Placebo

Sponsor

Instituto de Cardiología de Corrientes